CGI
BIIB icon

Comgest Global Investors’s Biogen BIIB Stock Holding History

Comgest Global Investors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-12,600
Closed -$2.95M – 49
2019
Q2 		$2.95M Buy
12,600
+200
+2% +$46.2K 0.06% 44
2019
Q1 		$2.93M Sell
12,400
-4,500
-27% -$1.42M 0.06% 44
2018
Q4 		$5.08M Hold
16,900
– – 0.13% 33
2018
Q3 		$5.97M Sell
16,900
-2,100
-11% -$723K 0.13% 30
2018
Q2 		$5.51M Hold
19,000
– – 0.12% 32
2018
Q1 		$5.2M Buy
19,000
+1,000
+6% +$310K 0.11% 31
2017
Q4 		$5.73M Buy
18,000
+1,000
+6% +$321K 0.12% 36
2017
Q3 		$5.32M Buy
17,000
+800
+5% +$237K 0.12% 37
2017
Q2 		$4.4M Hold
16,200
– – 0.11% 36
2017
Q1 		$4.43M Buy
16,200
+5,000
+45% +$1.41M 0.12% 35
2016
Q4 		$3.18M Sell
11,200
-1,200
-10% -$356K 0.1% 37
2016
Q3 		$3.88M Sell
12,400
-1,800
-13% -$533K 0.12% 32
2016
Q2 		$3.43M Buy
14,200
+4,200
+42% +$1.11M 0.1% 37
2016
Q1 		$2.6M Buy
+10,000
New +$2.64M 0.09% 37

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Comgest Global Investors's BIIB Position: Q3 2019 in Review

Comgest Global Investors sold out of Biogen (BIIB) in Q3 2019, closing a stake of 12,600 shares — an estimated $2.95M sold.

Comgest Global Investors first reported a position in BIIB in Q1 2016 and held it in 14 quarters. The position peaked at $5.97M in Q3 2018. 988 funds tracked by Wall St. Rank hold BIIB as of Q3 2019.

  • Comgest Global Investors reported no remaining Biogen position as of Q3 2019 after selling out during the quarter.
  • Comgest Global Investors sold 12,600 Biogen shares in Q3 2019, an estimated $2.95M.
  • Comgest Global Investors first reported a position in Biogen in Q1 2016 and held it in 14 quarters.
  • Comgest Global Investors's Biogen position peaked at $5.97M in Q3 2018.
  • 988 funds tracked by Wall St. Rank held Biogen as of Q3 2019.

Based on Comgest Global Investors's 13F filing for Q3 2019, filed 5 Nov 2019.